Back to News

Latest ISN Journal Editorial Selections

Kidney International®

Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis

The Kidney Disease: Improving Global Outcomes (KDIGO) has updated its Glomerular Diseases Guideline for lupus nephritis (LN) in response to accelerated drug development and new insights from genetic and molecular studies.

Read the updated guideline here

The most significant change involves strong recommendations for glucocorticoids combined with mycophenolic acid analogs and/or low-dose intravenous cyclophosphamide, alongside newly approved drugs (belimumab and voclosporin) where relevant.

The guideline also discusses maintenance immunosuppression, CKD progression, and ongoing evaluation of novel therapeutics for LN management.

Kidney International Reports®

Validation of a Core Patient-reported Outcome Measure for Life Participation in Kidney Transplant Recipients: The SONG Life Participation Instrument

In a study of 249 adult kidney transplant recipients from 20 countries, the SONG Life Participation instrument was demonstrated to be a simple, internally consistent, reliable measure for kidney transplant recipients and correlates with similar measures.

Help us advance kidney health worldwide
Join the ISN Subscribe to ISN Newsletter
Back to News